Tracey A. Ignatowski
Affiliations: | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Neuroscience BiologyGoogle:
"Tracey Ignatowski"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bloomingdale P, Meregalli C, Pollard K, et al. (2022) Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain. Frontiers in Pharmacology. 12: 817236 |
| Benson CA, Powell HR, Liput M, et al. (2020) Immune Factor, TNFα, Disrupts Human Brain Organoid Development Similar to Schizophrenia-Schizophrenia Increases Developmental Vulnerability to TNFα. Frontiers in Cellular Neuroscience. 14: 233 |
| LaMacchia ZM, Spengler RN, Jaffari M, et al. (2019) Perispinal injection of a TNF blocker directed to the brain of rats alleviates the sensory and affective components of chronic constriction injury-induced neuropathic pain. Brain, Behavior, and Immunity |
| Siemian JN, LaMacchia ZM, Spreuer V, et al. (2018) The imidazoline I2 receptor agonist 2-BFI attenuates hypersensitivity and spinal neuroinflammation in a rat model of neuropathic pain. Biochemical Pharmacology |
| Ignatowski TA, Spengler RN. (2018) Targeting tumor necrosis factor in the brain relieves neuropathic pain World Journal of Anesthesiology. 7: 10-19 |
| Fasick V, Spengler RN, Samankan S, et al. (2015) The hippocampus and TNF: Common links between chronic pain and depression. Neuroscience and Biobehavioral Reviews. 53: 139-59 |
| Gerard E, Spengler RN, Bonoiu AC, et al. (2015) Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factor. Pain. 156: 1320-33 |
| Ignatowski TA, Aalinkeel R, Reynolds JL, et al. (2015) Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 136-52 |
| Ignatowski TA, Spengler RN, Dhandapani KM, et al. (2014) Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence. Cns Drugs. 28: 679-97 |
| Tobinick E, Rodriguez-Romanacce H, Levine A, et al. (2014) Immediate neurological recovery following perispinal etanercept years after brain injury. Clinical Drug Investigation. 34: 361-6 |